Here are some of the recent stock purchases by company CEO:
For a complete list of stocks bought by their CEOs, go to: GuruFocus Insider Data.
CEO & Chairman, 10% Owner of Opko Health, Inc. (OPK, Financial) Dr. Phillip Frost bought46,200 shares at an average price of $9.59. Total transaction amount is $439,138. Opko Health is a biopharmaceutical and diagnostics company that is engaged in the discover, development, and commercialization of novel and proprietary technologies.
Market Cap: 3.92B, P/E: N/A
Business Reliability: 1/5, Financial Strength: 7/10, Profitability & Growth: 5/10
CEO, 10% Owner of Retrophin Inc (RTRX, Financial) Martin Shkreli bought 10,800 shares on 04/02/2014 at an average price of $22.28. Total transaction amount is $240,624. Retrophin is a biopharmaceutical company engaged in the discovery, development, and commercialization of orphan drugs for the treatment of rare life-threatening diseases.
Market Cap: 512.19M, P/E: N/A
Business Reliability: Not Rated, Financial Strength: 6/10, Profitability & Growth: 4/10
Chairman and CEO of Hyde Park Acquisition Corp II (HPAC, Financial) Laurence S Levy bought 40,000 shares on 04/02/2014 at an average price of $10.49. Total transaction amount is $419,600. Hyde Park Acquisition Corp II, a development stage company, intends to acquire through a merger, share exchange, asset acquisition, stock purchase, plan of arrangement, recapitalization, reorganization, or other similar business combination, one or more businesses, or entities.
Market Cap: 105.42M, P/E: N/A
Business Reliability: Not Rated, Financial Strength: 7/10, Profitability & Growth: 4/10
Chairman and CEO of Staples, Inc. (SPLS, Financial) Ronald Sargent bought 8,500 shares on 04/03/2014 at an average price of $11.82. Total transaction amount is $100,470. Staples operates office products superstores.
Market Cap: 7.87B, P/E: 12.70
Business Reliability: 1/5, Financial Strength: 7/10, Profitability & Growth: 6/10
